SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 152 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,000 | -26.7% | 2,550 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $15,000 | +66.7% | 2,550 | +104.0% | 0.00% | +50.0% |
| Q4 2021 | $9,000 | -90.6% | 1,250 | -87.6% | 0.00% | -96.4% |
| Q1 2019 | $96,000 | -52.0% | 10,050 | -42.2% | 0.06% | -57.3% |
| Q4 2018 | $200,000 | +1.5% | 17,400 | +49.4% | 0.13% | +28.4% |
| Q3 2018 | $197,000 | +95.0% | 11,650 | +1.3% | 0.10% | +61.9% |
| Q2 2017 | $101,000 | -39.5% | 11,500 | -64.3% | 0.06% | -39.4% |
| Q1 2017 | $167,000 | +11.3% | 32,200 | -34.6% | 0.10% | +10.6% |
| Q4 2016 | $150,000 | -28.9% | 49,200 | +8.1% | 0.09% | -30.4% |
| Q3 2016 | $211,000 | -25.7% | 45,500 | -7.1% | 0.14% | -26.6% |
| Q2 2016 | $284,000 | +8.0% | 49,000 | +12.6% | 0.18% | +4.5% |
| Q1 2016 | $263,000 | +64.4% | 43,500 | +148.6% | 0.18% | +70.9% |
| Q4 2015 | $160,000 | – | 17,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |